These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31346312)

  • 1. Elimination of lymphatic filariasis as a public health problem from Tonga.
    Ofanoa R; Ofa T; Padmasiri EA; Kapa DR
    Trop Med Health; 2019; 47():43. PubMed ID: 31346312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of lymphatic filariasis as a public health problem from the Cook Islands.
    Ave C; Kapa DR; Ottesen E
    Trop Med Health; 2018; 46():12. PubMed ID: 29785168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of lymphatic filariasis as a public health problem in Malawi.
    Chiphwanya J; Mkwanda S; Kabuluzi S; Mzilahowa T; Ngwira B; Matipula DE; Chaponda L; Ndhlova P; Katchika P; Mahebere Chirambo C; Moses P; Kumala J; Chiumia M; Barrett C; Betts H; Fahy J; Rebollo Polo M; Reimer L; Stanton MC; Thomas B; Freer S; Molyneux DH; Bockarie MJ; Mackenzie CD; Taylor MJ; Martindale S; Kelly-Hope LA
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011957. PubMed ID: 38363794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic filariasis in Fiji: progress towards elimination, 1997-2007.
    Manolas RK; Kama M; Rainima-Qaniuci M; Bechu VD; Tuibeqa S; Winston MV; Ram N; Naqio F; Ichimori K; Capuano C; Ozaki M; Kim SH; Aratchige P; Sahukhan A; Graves PM
    Trop Med Health; 2020; 48():88. PubMed ID: 33132735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of lymphatic filariasis as a public health problem in Niue under PacELF, 1999-2016.
    Carlingford CN; Melrose W; Mokoia G; Graves PM; Ichimori K; Capuano C; Kim SH; Aratchige P; Nosa M
    Trop Med Health; 2019; 47():20. PubMed ID: 30923457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from the Pacific programme to eliminate lymphatic filariasis: a case study of 5 countries.
    Huppatz C; Capuano C; Palmer K; Kelly PM; Durrheim DN
    BMC Infect Dis; 2009 Jun; 9():92. PubMed ID: 19523192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
    Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
    Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control and elimination of lymphatic filariasis in Oceania: Prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998-2017.
    Graves PM; Joseph H; Coutts SP; Mayfield HJ; Maiava F; Ah Leong-Lui TA; Tupuimatagi Toelupe P; Toeaso Iosia V; Loau S; Pemita P; Naseri T; Thomsen R; Berg Soto A; Burkot TR; Wood P; Melrose W; Aratchige P; Capuano C; Kim SH; Ozaki M; Yajima A; Lammie PJ; Ottesen E; Hansell L; Baghirov R; Lau CL; Ichimori K
    Adv Parasitol; 2021; 114():27-73. PubMed ID: 34696844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997-2006.
    Allen T; Taleo F; Graves PM; Wood P; Taleo G; Baker MC; Bradley M; Ichimori K
    Trop Med Health; 2017; 45():8. PubMed ID: 28579911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How elimination of lymphatic filariasis as a public health problem in the Kingdom of Cambodia was achieved.
    Khieu V; Or V; Tep C; Odermatt P; Tsuyuoka R; Char MC; Brady MA; Sidwell J; Yajima A; Huy R; Ramaiah KD; Muth S
    Infect Dis Poverty; 2018 Feb; 7(1):15. PubMed ID: 29463307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa.
    Yokoly FN; Zahouli JBZ; Méite A; Opoku M; Kouassi BL; de Souza DK; Bockarie M; Koudou BG
    PLoS One; 2020; 15(4):e0231541. PubMed ID: 32282840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya.
    Njenga SM; Kanyi HM; Mutungi FM; Okoyo C; Matendechero HS; Pullan RL; Halliday KE; Brooker SJ; Wamae CN; Onsongo JK; Won KY
    Parasit Vectors; 2017 Feb; 10(1):99. PubMed ID: 28228160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
    de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
    Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic Filariasis Elimination Status:
    Matapo BB; Mpabalwani EM; Kaonga P; Simuunza MC; Bakyaita N; Masaninga F; Siyumbwa N; Siziya S; Shamilimo F; Muzongwe C; Mwase ET; Sikasunge CS
    Trop Med Infect Dis; 2023 Jun; 8(7):. PubMed ID: 37505629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
    Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
    Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
    Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
    Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.